Literature DB >> 18765632

Heritability of the severity of diabetic retinopathy: the FIND-Eye study.

Nedal H Arar1, Barry I Freedman, Sharon G Adler, Sudha K Iyengar, Emily Y Chew, Mathew D Davis, Scott G Satko, Donald W Bowden, Ravi Duggirala, Robert C Elston, Xiuxing Guo, Robert L Hanson, Robert P Igo, Eli Ipp, Paul L Kimmel, William C Knowler, Julio Molineros, Robert G Nelson, Madeleine V Pahl, Shannon R E Quade, Rebekah S Rasooly, Jerome I Rotter, Mohammed F Saad, Marina Scavini, Jeffrey R Schelling, John R Sedor, Vallabh O Shah, Philip G Zager, Hanna E Abboud.   

Abstract

PURPOSE: Diabetic retinopathy (DR) and diabetic nephropathy (DN) are serious microvascular complications of diabetes mellitus. Correlations between severity of DR and DN and computed heritability estimates for DR were determined in a large, multiethnic sample of diabetic families. The hypothesis was that (1) the severity of DR correlates with the presence and severity of nephropathy in individuals with diabetes mellitus, and (2) the severity of DR is under significant familial influence in members of multiplex diabetic families.
METHODS: The Family Investigation of Nephropathy and Diabetes (FIND) was designed to evaluate the genetic basis of DN in American Indians, European Americans, African Americans, and Mexican Americans. FIND enrolled probands with advanced DN, along with their diabetic siblings who were concordant and discordant for nephropathy. These diabetic family members were invited to participate in the FIND-Eye study to determine whether inherited factors underlie susceptibility to DR and its severity. FIND-Eye participants underwent eye examinations and had fundus photographs taken. The severity of DR was graded by using the Early Treatment Diabetic Retinopathy Study Classification (ETDRS). Sib-sib correlations were calculated with the SAGE 5.0 program FCOR, to estimate heritability of retinopathy severity.
RESULTS: This report summarizes the results for the first 2368 diabetic subjects from 767 families enrolled in FIND-Eye; nearly 50% were Mexican American, the largest single ethnicity within FIND. The overall prevalence of DR was high; 33.4% had proliferative DR; 7.5%, 22.8%, and 9.5% had severe, moderate, and mild nonproliferative DR, respectively; 26.6% had no DR. The severity of DR was significantly associated with severity of DN, both by phenotypic category and by increasing serum creatinine concentration (chi(2) = 658.14, df = 20; P < 0.0001). The sib-sib correlation for DR severity was 0.1358 in the total sample and 0.1224 when limited to the Mexican-American sample. Broad sense heritabilities for DR were 27% overall and 24% in Mexican-American families. The polygenic heritability of liability for proliferative DR approximated 25% in this FIND-Eye sample.
CONCLUSIONS: These data confirm that the severity of DR parallels the presence and severity of nephropathy in individuals with diabetes mellitus. The severity of DR in members of multiplex diabetic families appears to have a significant familial connection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765632      PMCID: PMC2583147          DOI: 10.1167/iovs.07-1633

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

1.  UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

Authors:  I M Stratton; E M Kohner; S J Aldington; R C Turner; R R Holman; S E Manley; D R Matthews
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

2.  Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients.

Authors:  Roberto Trevisan; Monica Vedovato; Cinzia Mazzon; Anna Coracina; Elisabetta Iori; Antonio Tiengo; Stefano Del Prato
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

3.  Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2.

Authors:  Michael Guccione; Sharon Silbiger; Jun Lei; Joel Neugarten
Journal:  Am J Physiol Renal Physiol       Date:  2002-01

4.  Heritability of albumin excretion rate in families of patients with Type II diabetes.

Authors:  C M Forsblom; T Kanninen; M Lehtovirta; C Saloranta; L C Groop
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

5.  Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients.

Authors:  M Rema; G Saravanan; R Deepa; V Mohan
Journal:  Diabet Med       Date:  2002-11       Impact factor: 4.359

6.  Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study.

Authors:  Rohit Varma; Ginger L Macias; Mina Torres; Ronald Klein; Fernando Y Peña; Stanley P Azen
Journal:  Ophthalmology       Date:  2007-02-16       Impact factor: 12.079

7.  Microalbuminuria in the US population: third National Health and Nutrition Examination Survey.

Authors:  Camille A Jones; Mildred E Francis; Mark S Eberhardt; Blanche Chavers; Josef Coresh; Michael Engelgau; John W Kusek; Danita Byrd-Holt; K M Venkat Narayan; William H Herman; Camara P Jones; Marcel Salive; Lawrence Y Agodoa
Journal:  Am J Kidney Dis       Date:  2002-03       Impact factor: 8.860

Review 8.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

9.  Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in pima indians.

Authors:  Helen C Looker; Jonathan Krakoff; William C Knowler; Peter H Bennett; Ronald Klein; Robert L Hanson
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

10.  Segregation analysis of diabetic nephropathy in Pima Indians.

Authors:  G Imperatore; W C Knowler; D J Pettitt; S Kobes; P H Bennett; R L Hanson
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

View more
  72 in total

Review 1.  Progress in Defining the Genetic Basis of Diabetic Complications.

Authors:  Emma Dahlström; Niina Sandholm
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

Review 2.  The role of genetics in susceptibility to diabetic retinopathy.

Authors:  Gerald Liew; Ronald Klein; Tien Y Wong
Journal:  Int Ophthalmol Clin       Date:  2009

Review 3.  Challenges in elucidating the genetics of diabetic retinopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Jerome I Rotter
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

Review 4.  Genetics of diabetic retinopathy.

Authors:  Heeyoon Cho; Lucia Sobrin
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

Review 5.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

Review 6.  Recent progress in the genetics of diabetic microvascular complications.

Authors:  Yi-Cheng Chang; Emily Yun-Chia Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2015-06-10

7.  Replication analysis for severe diabetic retinopathy.

Authors:  Michael A Grassi; Anna Tikhomirov; Sudha Ramalingam; Kristine E Lee; S M Hosseini; Barbara E K Klein; Ronald Klein; Yves A Lussier; Nancy J Cox; Dan L Nicolae
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-30       Impact factor: 4.799

8.  Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas.

Authors:  Yi-Ping Fu; D Michael Hallman; Victor H Gonzalez; Barbara E K Klein; Ronald Klein; M Geoffrey Hayes; Nancy J Cox; Graeme I Bell; Craig L Hanis
Journal:  J Ophthalmol       Date:  2010-09-02       Impact factor: 1.909

9.  Human genetics of diabetic retinopathy: current perspectives.

Authors:  Daniel P K Ng
Journal:  J Ophthalmol       Date:  2010-07-13       Impact factor: 1.909

10.  A systematic meta-analysis of genetic association studies for diabetic retinopathy.

Authors:  Sotoodeh Abhary; Alex W Hewitt; Kathryn P Burdon; Jamie E Craig
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.